ALDH2 mediates the dose-response protection of chronic ethanol against endothelial senescence through SIRT1/p53 pathway

Aldehyde dehydrogenase 2 (ALDH2) plays essential roles in drinking-associated diseases or effects. As we have previously reported, ALDH2 mediates acute ethanol-induced eNOS activation in vitro. However, whether chronic ethanol treatment has a dose-response endothelial protection, as well as the poss...

Full description

Saved in:
Bibliographic Details
Published inBiochemical and biophysical research communications Vol. 504; no. 4; pp. 777 - 783
Main Authors Xue, Li, Yang, Feihong, Han, Ziqi, Cui, Sumei, Dai, Shuai, Xu, Feng, Zhang, Chuanxin, Wang, Xuping, Pang, Jiaojiao, Pan, Chang, Chen, Yuguo
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 12.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aldehyde dehydrogenase 2 (ALDH2) plays essential roles in drinking-associated diseases or effects. As we have previously reported, ALDH2 mediates acute ethanol-induced eNOS activation in vitro. However, whether chronic ethanol treatment has a dose-response endothelial protection, as well as the possible mediating role of ALDH2 involved, is unclear. Here, we show that appropriate dose of ethanol preserved the expression and activity of ALDH2 and eNOS, and alleviated senescence-associated phenotypes in human aortic endothelial cells. Furthermore, ALDH2 deficiency impairs the dose-response protection of ethanol against endothelial senescence by promoting the accumulation of 4-HNE, the formation of 4-HNE-SIRT1 protein adducts and the subsequent decrease in SIRT1-dependent p53 deacetylation. Collectively, our data indicate that ALDH2 mediates the protection of appropriate ethanol by modulating SIRT1/p53-dependent endothelial senescence. •Chronic ethanol exerts dose-response protection against endothelial senescence.•Chronic appropriate dose of ethanol upregulates ALDH2 expression and activity.•ALDH2 deficiency inhibits ethanol protection by producing 4-HNE-SIRT1 adducts.•4-HNE-SIRT1 blocks the translocation of SIRT1 from the cytoplasm to the nucleus.•Cytoplasmic SIRT1 promotes endothelial senescence by increasing p53 acetylation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2018.08.081